Tag: #Global Trends

Merck KGaA has entered into a collaborative agreement with Remepy to develop integrated "hybrid drugs" that merge pharmacological treatments with... Read more

A milestone in automated autologous CAR-T production Cellares and Cabaletta Bio have formalized a 10-year commercial supply agreement, marking a... Read more

Leveraging operational insights to accelerate commercialization Following an initial phase of navigating capacity constraints and logistical hurdles in the CAR-T... Read more

Becton, Dickinson and Company (BD) and Suttons Creek have entered into a strategic collaboration to assist pharmaceutical and biotech firms... Read more

Thermo Fisher Scientific Inc. has inaugurated its flagship U.S. Bioprocess Design Center (BDC) at its Plainville, Massachusetts site. This expansion... Read more

April 2026 continues to be a landmark month for biotechnology IPOs as Seaport Therapeutics and Hemab Therapeutics both outline their... Read more

GSK’s Tesaro unit has suffered a legal setback in its dispute with Jemperli developer AnaptysBio, as a Delaware court dismissed... Read more

The US Food and Drug Administration (FDA) has approved a subcutaneous autoinjector version of Saphnelo (anifrolumab) for adult patients suffering... Read more

European drug regulators have issued a positive review for Sanofi’s experimental multiple sclerosis (MS) treatment. This move comes after the... Read more